Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
,
pharmacokinetics
,
lymphoma
,
non-hodgkin lymphoma
,
acrocephalosyndactylia
,
endometrioid carcinoma
,
peritoneal neoplasms
,
hereditary breast and ovarian cancer syndrome
,
malignant mesothelioma
,
mesothelioma
,
pharmacological phenomena
,
sarcoma
,
adenocarcinoma
,
carcinosarcoma
,
digestive system neoplasms
,
urinary bladder neoplasms
,
neuroendocrine tumors
,
islet cell adenoma
,
urogenital neoplasms
,
female genital neoplasms
,
esophageal neoplasms
,
colonic neoplasms
,
spinocerebellar degenerations
,
fibrosis
,
inguinal hernia
,
hernia
,
gangrene
,
ovarian neoplasms
,
non-small-cell lung carcinoma
,
endometrial neoplasms
,
prostatic neoplasms
,
ovarian epithelial carcinoma
,
colorectal neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
lung neoplasms
,
postmenopause
,
castration-resistant prostatic neoplasms
,
fallopian tube neoplasms
,
small cell lung carcinoma
,
breast diseases
,
stomach neoplasms
,
ductal carcinoma
,
liposarcoma
,
pancreatic neoplasms
,
carcinoma in situ
,
head and neck neoplasms
,
neoplasms by site
,
urologic neoplasms
,
uterine neoplasms
,
brain neoplasms
,
circulating neoplastic cells
,
intraductal carcinoma noninfiltrating
,
syndrome
,
melanoma
,
transitional cell carcinoma
,
squamous cell carcinoma
,
radiosurgery
,
biliary tract neoplasms
,
adenocarcinoma of lung
,
serous cystadenocarcinoma
,
leiomyosarcoma
,
adenosarcoma
,
sex cord-gonadal stromal tumors
,
endometrial stromal sarcoma
,
bone neoplasms
,
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
systemic lupus erythematosus
,
precocious puberty
,
polyostotic fibrous dysplasia
,
inborn genetic diseases
,
neutropenia
,
insulin resistance
,
hyperglycemia
,
hyperinsulinism
,
molecular targeted therapy
,
large b-cell lymphoma diffuse
,
salivary gland neoplasms
,
therapeutics
,
myxoid liposarcoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
skin neoplasms
,
diarrhea
,
exanthema
,
carcinoma
,
recurrence
,
male breast neoplasms
,
hereditary sensory and autonomic neuropathies
,
invasive hydatidiform mole
,
disease progression
,
lobular carcinoma
,
ductal carcinoma breast
,
neoadjuvant therapy
,
progression-free survival
,
cholangiocarcinoma
,
unilateral breast neoplasms
,
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
neoplasm metastasis
,
multiple endocrine neoplasia type 1
,
eye abnormalities
Eribulin
breast neoplasms
,
neoplasms
Eribulin mesylate
breast neoplasms
,
neoplasms
Sacituzumab
neoplasms
,
esophageal neoplasms
,
esophageal squamous cell carcinoma
,
neoplasm metastasis
,
colorectal neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
urologic neoplasms
,
transitional cell carcinoma
,
non-muscle invasive bladder neoplasms
,
brain neoplasms
,
recurrence
,
adenoid cystic carcinoma
,
papillary thyroid cancer
,
prostatic neoplasms
,
disease progression
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lung neoplasms
,
endometrial neoplasms
,
uterine cervical neoplasms
,
ovarian neoplasms
,
carcinoma
,
fallopian tube neoplasms
,
urinary bladder neoplasms
Mycophenolate sodium
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
multiple myeloma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
hodgkin disease
,
t-cell lymphoma peripheral
,
myeloid leukemia
,
lymphoid leukemia
Benzimidazole
healthy volunteers/patients
Sintilimab
non-small-cell lung carcinoma
,
lung neoplasms
Penpulimab
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
gastrointestinal neoplasms
,
colorectal neoplasms
,
pancreatic neoplasms
,
nasopharyngeal neoplasms
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
thyroid neoplasms
,
small cell lung carcinoma
,
glioblastoma
,
stomach neoplasms
,
gastrointestinal diseases
,
digestive system diseases
,
nasopharyngeal carcinoma
,
rectal neoplasms
,
lymphoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
esophageal squamous cell carcinoma
,
sarcoma
,
melanoma
,
pheochromocytoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Cadonilimab
glioblastoma
,
skin neoplasms
,
neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
neoplasm metastasis
,
melanoma
,
renal cell carcinoma
,
cholangiocarcinoma
,
pancreatic neoplasms
,
small cell lung carcinoma
,
esophageal neoplasms
,
endometrial neoplasms
,
immunotherapy
,
triple negative breast neoplasms
,
sarcoma
,
biliary tract neoplasms
,
urinary bladder neoplasms
,
squamous cell carcinoma of head and neck
,
breast neoplasms
,
squamous cell neoplasms
,
microsatellite instability
,
brain neoplasms
,
endometrioid carcinoma
,
thrombosis
,
radiosurgery
,
malignant mesothelioma
,
mesothelioma
,
ductal carcinoma
,
urologic neoplasms
,
kidney neoplasms
,
lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
hypertension
,
portal hypertension
,
vulvar neoplasms
,
invasive hydatidiform mole
,
bile duct neoplasms
,
salivary gland neoplasms
,
transitional cell carcinoma
,
mutation rate
,
hysterectomy
,
recreational drug use
,
local neoplasm recurrence
,
pancreatic ductal carcinoma
,
meningeal carcinomatosis
,
carcinoma
,
hepatocellular carcinoma
,
uterine cervical neoplasms
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
liver neoplasms
,
adenocarcinoma
,
stomach neoplasms
,
lung neoplasms
,
recurrence
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
neoadjuvant therapy
,
healthy volunteers/patients
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
rectal neoplasms
,
drug therapy
,
radiotherapy
,
adjuvant chemotherapy
,
cryosurgery
,
small cell carcinoma
,
neuroendocrine carcinoma
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
fatty liver
,
type 2 diabetes mellitus
,
diabetes mellitus
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
liver diseases
,
fibrosis
Gilvetmab
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
squamous cell carcinoma
Enoblituzumab
healthy volunteers/patients
,
knee osteoarthritis
,
osteoarthritis
,
tinea
,
tinea pedis
Efbemalenograstim alfa
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
colorectal neoplasms
,
pancreatic neoplasms
,
ovarian neoplasms
,
uterine cervical neoplasms
,
neutropenia
,
breast neoplasms
,
neoplasms
Aglatimagene besadenovec
breast neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
lung neoplasms
,
glioblastoma
,
small cell lung carcinoma
,
neuroendocrine carcinoma
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
,
head and neck neoplasms
,
esophageal neoplasms
,
gastrointestinal neoplasms
,
sarcoma
,
urogenital neoplasms
,
skin neoplasms
,
melanoma
,
colonic neoplasms
,
healthy volunteers/patients
Spartalizumab
ovarian neoplasms
,
lung neoplasms
,
neoplasm metastasis
,
kidney neoplasms
,
leukemia
,
myeloid leukemia acute
,
hematologic diseases
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
bone marrow diseases
,
syndrome
,
colonic neoplasms
,
rectal neoplasms
,
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
,
glioblastoma
,
multiple myeloma
,
plasma cell neoplasms
,
alveolar soft part sarcoma
,
chordoma
,
neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
colorectal neoplasms
,
carcinoma
,
breast neoplasms
,
renal cell carcinoma
,
pancreatic neoplasms
,
hepatocellular carcinoma
,
lymphoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
adenocarcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
pancreatic ductal carcinoma
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
ovarian epithelial carcinoma
,
gastrointestinal stromal tumors
,
sarcoma
,
anus neoplasms
,
small cell lung carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
prostatic neoplasms
,
large b-cell lymphoma diffuse
,
neuroendocrine tumors
,
urologic neoplasms
,
thyroid neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
unknown primary neoplasms
,
adenocarcinoma of lung
,
clear cell adenocarcinoma
,
mesothelioma
,
carcinosarcoma
,
uveal neoplasms
,
adenomyoepithelioma
,
uveal melanoma
,
hematologic neoplasms
,
castration-resistant prostatic neoplasms
,
b-cell lymphoma
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
neuroendocrine carcinoma
,
endometrial neoplasms
,
anaplastic thyroid carcinoma
,
melanoma
,
skin neoplasms
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use